News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nutra Pharma Corp. (NPHC) Release: Designer Diagnostics Inc. Announces Positive Results From In-Vitro Analysis



1/18/2007 12:08:10 PM

BOCA RATON, Fla.--(BUSINESS WIRE)--Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has today announced that its subsidiary, Designer Diagnostics, has received positive results from its in-vitro analysis of its Tuberculosis (TB) test kit.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES